Phibro Animal Health Corporation — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+20.9% +$65M
$374M
Cost of Revenue↑+16.3% +$34M
$241M
Gross Profit↑+30.2% +$31M
$133M
SG&A↑+7.9% +$6M
$82M
D&A↑+11.4% +$1M
$13M
Operating Income↑+97.1% +$25M
$50M
EBITDA↑+70.4% +$26M
$63M
Interest Expense↑+27.6% +$3M
$12M
Interest Income
—
Other Income/Expense↑+87.0% +$9M
$-1M
Pretax Income↑+652.9% +$32M
$36M
Tax Provision↑+442.4% +$7M
$9M
Net Income↑+762.1% +$24M
$27M
Gross Margin↑+2.5pts
35.5%
Operating Margin↑+5.2pts
13.5%
Net Margin↑+6.3pts
7.3%
Effective Tax Rate↓-9.6pts
24.6%
Deferred Tax Assets↓-7.8% -$2M
$24M
Deferred Tax Liabilities
—
ETR (Continuing Operations)↓-48.9pts
29.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+1.7pts
0.6%
ETR Foreign Differential (pp)↓-10.5pts
-0.6%
Operating Lease Cost↑+30.8% +$921K
$4M
Pension Net Periodic Cost
—
Revenue YoY Variation↓-2.8pts
20.9%
Income YoY Variation↑+34.5pts
97.1%
Revenue QoQ Variation↓-16.0pts
2.8%
Income QoQ Variation↓-46.1pts
-1.8%